Related Experiment Video
Updated: Aug 15, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Variation of the Mycobacterium tuberculosis PE_PGRS 33 gene among clinical isolates
Sarah Talarico1, M Donald Cave, Carl F Marrs
1Epidemiology Department, School of Public Health, University of Michigan, 109 S. Observatory Street, Ann Arbor, MI 48109-2029, USA.
Abstract:
PE_PGRS 33, one of about 60 PE_PGRS genes in the Mycobacterium tuberculosis genome, encodes a surface-expressed protein that may be involved in the antigenic variation of M. tuberculosis strains and evasion of the host immune system. While genetic differences between the PE_PGRS 33 genes of H37Rv and CDC 1551 have been noted, genetic variation in this gene among clinical isolates has not been evaluated. In order to gain a better understanding of the genetic basis for the role of PE_PGRS in antigenic variation and evasion of the host immune system, we investigated the genetic diversity of the PE_PGRS 33 gene among 123 clinical M. tuberculosis isolates from a population-based study, using PCR and DNA sequencing. The 123 isolates belonged to principal genetic groups 1, 2, and 3 and had IS 6110 copy numbers ranging from 1 to 22. Eighty-four (68.3%) of the 123 isolates were found to have at least one sequence variation in the PE_PGRS 33 gene, relative to that of H37Rv. Twenty-five different sequence variations were observed and included three insertions (ranging from 9 to 87 bp), nine deletions (ranging from 1 to 273 bp), one insertion-and-deletion event, and 12 single-nucleotide polymorphisms (six synonymous and six nonsynonymous). Analysis of the relationships among the different PE_PGRS 33 gene sequence variations suggests that polymorphisms in the gene are shifting along evolutionary lineages. The observed genetic diversity of the PE_PGRS 33 gene supports its role in antigenic variation and can serve as a basis for future investigations of the function of the PE_PGRS 33 gene among clinical isolates.
Insights
Genetic diversity in the PE_PGRS 33 gene of Mycobacterium tuberculosis was analyzed in 123 clinical isolates. Significant variations were found, supporting its role in immune evasion and antigenic variation.
Area of Science:
- Microbiology
- Genetics
- Immunology
Background:
- The PE_PGRS 33 gene in Mycobacterium tuberculosis is implicated in antigenic variation and immune system evasion.
- Previous studies noted genetic differences in PE_PGRS 33 between reference strains, but variation in clinical isolates remained unevaluated.
Purpose of the Study:
- To investigate the genetic diversity of the PE_PGRS 33 gene in clinical Mycobacterium tuberculosis isolates.
- To understand the genetic basis of PE_PGRS 33's role in antigenic variation and immune evasion.
Main Methods:
- PCR and DNA sequencing were used to analyze the PE_PGRS 33 gene.
- 123 clinical Mycobacterium tuberculosis isolates from a population-based study were examined.
Main Results:
- 68.3% of isolates (84/123) exhibited sequence variations in the PE_PGRS 33 gene compared to the H37Rv strain.
- Twenty-five distinct variations were identified, including insertions, deletions, and single-nucleotide polymorphisms (synonymous and nonsynonymous).
- Polymorphisms in the PE_PGRS 33 gene appear to shift along evolutionary lineages.
Conclusions:
- The study reveals significant genetic diversity within the PE_PGRS 33 gene among clinical Mycobacterium tuberculosis isolates.
- This genetic variation supports the proposed role of PE_PGRS 33 in antigenic variation and host immune system evasion.
- Further research into the functional implications of PE_PGRS 33 diversity in clinical settings is warranted.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Evolution of Microbial Genome
Modern Molecular Taxonomy